5 Takeways from The Liver Meeting (AASLD) in DC – November 2025
1]. Bloodwork is becoming more discerning in liver disease, e.g., Helio Genomics in HCC.
2]. New modalities are on the rise around the Liver MRI, e.g., Resoundant and Perspectum.
3]. Because of the 42% prevalence, Pharmas are racing or have raced to Liver Disease meds.
4]. There continues to be a stellar set of Advocacy Organizations such as — to name just one — Hepatitis B Foundation who are relentlessly and creatively focused on driving up awareness of liver disease of all types.
5]. The many posters presented by researchers indicates there’s only more innovation to come to Liver Disease, all subtypes. The liver has been wildly ignored for years. No longer.
